Jane Street Group, LLC Immunity Bio, Inc. Call Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2025 Nov 13, 2025	SELL	$2.24 - $3.01 $6,048 - $8,126	-2,700 Reduced 0.46%	581,700 $1.43 Million
Q2 2025 Aug 14, 2025	BUY	$1.89 - $3.44 $898,317 - $1.64 Million	475,300 Added 435.66%	584,400 $1.54 Million
Q1 2025 May 14, 2025	BUY	$2.32 - $3.9 $80,736 - $135,720	34,800 Added 46.84%	109,100 $328,000
Q4 2024 Feb 14, 2025	SELL	$2.56 - $6.17 $1.51 Million - $3.64 Million	-589,800 Reduced 88.81%	74,300 $190,000
Q3 2024 Nov 14, 2024	BUY	$3.32 - $6.7 $2.2 Million - $4.45 Million	664,100 New	664,100 $2.46 Million
Q1 2022 May 17, 2022	SELL	$5.05 - $7.53 $317,140 - $472,884	-62,800 Reduced 57.09%	47,200 $265,000
Q4 2021 Feb 15, 2022	BUY	$5.67 - $10.18 $112,833 - $202,582	19,900 Added 22.09%	110,000 $669,000
Q3 2021 Nov 16, 2021	SELL	$9.17 - $14.24 $15,589 - $24,208	-1,700 Reduced 1.85%	90,100 $878,000
Q2 2021 Aug 16, 2021	SELL	$13.41 - $22.4 $872,991 - $1.46 Million	-65,100 Reduced 41.49%	91,800 $1.31 Million
Q1 2021 May 18, 2021	BUY	$12.83 - $42.25 $2.01 Million - $6.63 Million	156,900 New	156,900 $3.73 Million

297

137M

2.59M

3.35M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $833M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.